Webinars
Plasmid Platform Facilitates Transition to Clinic
Summary: Securing the supply of this critical raw material will help biotech and pharma companies throughout the drug development lifecycle of their advanced therapies.
View Now
Podcast
Platform Processes for Streamlined Regulatory Filing and Decreased Time to Market for Gene Therapies
Summary: In this podcast, we will discuss how Catalent is working to simplify the supply chain, develop processes scalable for late-stage and commercial needs, and accelerate timelines for production of clinical materials.
View Now
Webinars
Accelerating Advances in Cell and Gene Therapy Production
Summary: During this webinar, we reviewed progress in several areas of advanced development and their impact on readiness for large scale manufacturing.
View Now
Video
Plasmid DNA: Integrated Solutions for Cell and Gene Therapies
Summary: Plasmid DNA is a critical raw material for cell and gene therapies. Discover the importance of having an integrated partner like Catalent Cell & Gene, and how we can keep your development and manufacturing on track and on schedule.
View Now
Offering Fact Sheet
Plasmid DNA Manufacturing
Summary: The Catalent team has broad expertise in developing customized plasmid DNA manufacturing solutions, from plasmid engineering to large-scale GMP plasmid production.
View Now
Article
Overcoming the Raw Material Hurdle: Plasmids for Viral Vector-Based Gene Therapies
Summary: Learn how Catalent Cell & Gene Therapy recognizes the challenges faced when obtaining raw materials, and how our investments in pDNA manufacturing secure our integrated supply chain.
View Now
Executive Summary
Readiness through Planning and Alignment: Guiding Gene Therapies from Clinic to Market
Summary: Learn how integrated service providers can streamline manufacturing, development and commercialization for optimal regulatory and process outcomes for gene therapy programs.
View Now
Executive Summary
Are Real-Time Gene Therapy Test Results Possible?
Summary: Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, in real-time.
View Now
Executive Summary
Formulation Strategies for AAV-Based Gene Therapies
Summary: In this executive summary, our expert discusses how Catalent Cell & Gene Therapy continues to learn about formulating gene therapies by adapting methods used for other biologics.
View Now
Webinars
Formulation and Characterization Strategies for Gene Therapies
Summary: In this on-demand webinar, our expert discusses how Catalent Cell and Gene Therapy is working towards an approach for gathering product knowledge and establishing formulation selection criteria using traditional/routine techniques as well as evaluating novel methodologies for gene therapy products.
View Now
